World population: 6.7 billion Global Prevalence Patients per million population (p.m.p.) Global View of ESRD Patients World population 1.2% ESRD~ 7% Haemodialysis7-8%

Slides:



Advertisements
Similar presentations
Chronic renal diseases as a public health problem Epidemiology, Social and Economical Implications Arrigo Schieppati Bellagio March 16, 2004.
Advertisements

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
 The Mayans  Easter Island  Mesopotamia  Biosphere
Treated ESRD Incidence Rates for Selected Countries, New ESRD Patients/Million Pop. Year of ESRD Incidence USA (All) JPN* USA (White) CAN FRA NL.
DEVELOPMENT OF STRATEGIES FOR PREVENTION OF CHRONIC KIDNEY DISEASE RELEVENT TO DIFFERENT REGIONS AND COUNTRIES ROBERT C ATKINS BELLAGIO, MARCH 2004.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
CHAPTER 2.4 Gross Domestic Product. Most economists view the country like one big business They measure the success of this business through gross domestic.
International Comparison. Economy 2 Basic Facts Country Population, million (2011) Currency GDP, billion $ (2011) GDP per capita (PPP), $ (2011) Corporate.
Aim: To identify global patterns and trends in oil consumption.
Population Density Look at the next slides. Do these places have high population densities or low population densities?
The Post American World Quiz #1 February 17, 2010.
Developed vs. Developing Countries: What you need to know for the quiz.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
Demographic Trends and Prospects Presented by: Eduard Bos Health, Nutrition, and Population The World Bank John Bongaarts, Population Council, contributed.
1 Announcing … Global broadband subscribers to 30 June 2005 Total: 176 million 115 million * 65% * choose DSL.
Eclipse Foundation, Inc. Eclipse Developer Demographic Profile Information Source Company: Genuitec LLC Product : MyEclispe Enterprise Workbench - 160,000.
9. Fundamental Concepts of Macroeconomics 1.Objectives and Methods of Macroeconomics 2.Economic Growth 3.National Accounting.
Countries Websites CIA world fact book Worldatlas.com National Geographic.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
By Isi and Karishma. 1) China-6,973,900,000 2) India-1,339,724,852 3) America-312, 582,000 4) Indonesia-237,641,326 5) Brazil-190, 755, 799 6) Pakistan-177,807,000.
Kuwait Healthcare The Challenge of Global Medical Tourism James A. Rice, Ph.D. James A. Rice, Ph.D.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
How free markets create & divide wealth
GDP that is measured at current prices is called GDP that has been adjusted for any price changes over time is called Let’s see how it works through one.
How free markets create & divide wealth
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
Gross Domestic Product IB Global Politics UWC Costa Rica.
ESRD Prognoses James Heaf. This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.
2016 Annual Data Report, Vol 2, ESRD, Ch 13
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
Publish Date : April 2017 No. of Pages : 200 Geography Coverage : 10 Countries Price for Single User Licence : USD 1690 Price for.
UK Renal Registry 18th Annual Report
Top 10 Markets by HNWI Population
Volume 59, Issue 2, Pages (February 2001)
First-year death rates by modality figure 8
West Midlands Renal Peer Review
Prevalence (pmp) of Renal Replacement Therapy
Fig 7.1 Median URR achieved in each renal unit
December 31st point prevalent counts by modality figure 3.1
10 Most Populated Country in the World.
The World Market.
UK Renal Registry 9th Annual Report 2006
Embolic Protection Devices Market Analysis, Share, Trend Industry Report, 2024
UK Renal Registry 10th Annual Report 2007
CHAPTER 5 Paediatric Renal Replacement Therapy
The Changing World Order
Population Practice Problems
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
Global burden of hypertension in the adult population
CHAPTER 1 All Renal Replacement Therapy In Malaysia
Globalization Wrap-up
CHAPTER 10 Hepatitis on Dialysis
UK Renal Registry 16th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
American Journal of Kidney Diseases
Estimated number of people living with HIV and adult HIV prevalence
Gross Domestic Product
Varying Patterns of ESKD Care Globally: Achieving Equity
2006 Rank Adjusted for Purchasing Power
Worldwide incidence of ESRD figure 12.1, per million population
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Volume 59, Issue 2, Pages (February 2001)
Prevalent Dialysis and Transplants Australia (at 31st December) Number of Patients
Stock and Flow of Peritoneal Dialysis Patients Australia
Australia and New Zealand
Australia and New Zealand
Presentation transcript:

World population: 6.7 billion Global Prevalence Patients per million population (p.m.p.) Global View of ESRD Patients World population 1.2% ESRD~ 7% Haemodialysis7-8% Peritoneal Dialysis ~ 7% Transplants ~ 6% Growth Rates ESRD Patients 2,310,000  thereof Dialysis 1,775,000(77%) HD 1,585,000(69%) PD 190,000 (8%)  thereof Transplants535,000 (23%) Global Prevalence Development Dialysis patients per million population (p.m.p.)

Patient Numbers thousands estimation 1,775,000 Dialysis Patients EU 17% Japan 16% Other 46% USA 21% HD - PD Split HD 89% PD 11% Global View of Dialysis Patients USA % EU % Japan % Other % Total ~ 7 % Growth Rates Source: FME Market and Competitor Survey, % 20% 21% 25% 46% 16% 17% 21% 49% 15% 16% 20%

Country (millions)population Dialysis (thousands) % of total patients Dialysis prevalence (p.m.p.) Global6,7401, Population% of worldpatientsdialysis USA3055%37121%21%1,215 Japan1272%28716%2,250 Germany821%764%925 Brazil1983%885%450 China1,33420%945%70 Countries ,71725%40723%235 Countries ,79241%45226%160 Countries %00%0 Relative Population Profiles